Healthcare and Pharmaceuticals industry

Recombinant Human Follitropin Sales Market By Type, Size, And Application: Global Opportunity Analysis And Industry Forecast, 2020-2026




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Recombinant Human Follitropin Sales Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2020. 

Follicle Stimulating Hormone (FSH) can be obtained by purifying urine from menopausal women and extract FSH and luteinizing hormone (LH). FSH can also be obtained by using recombinant DNA technique.

Market Dynamics

High prevalence of infertility is expected to propel growth of the recombinant human follitropin market over the forecast period. For instance, according to the National Survey of Family Growth data published in September 2018, 15.5% of all women who intend to become pregnant are infertile and 6.7% of married women aged 15 to 44 years are infertile, in the U.S.

Increasing funding for R&D in polycystic ovary syndrome treatment is expected to offer lucrative growth opportunities for players in the recombinant human follitropin market. For instance, in 2019, Wellcome Trust funded a US$ 3 million project that observed 1,000 women suffering from polycystic ovary syndrome in three studies including the testing of a new drug.

Moreover, high prevalence of polycystic ovary syndrome is also expected to propel growth of the market. For instance, according to the study ‘The prevalence of polycystic ovary syndrome in adolescents: A systematic review and meta-analysis’, published in September 2019, the prevalence of polycystic ovarian syndrome in adolescents based on the Rotterdam criteria was 11.04%, based on the National Institute of Health criteria, it was 3.39%, and based on Androgen Excess and Polycystic Ovary Syndrome Society, it was 8.03%.

Major players operating in the recombinant human follitropin market are focused on approval and launch of new products to expand their product portfolio. For instance, in 2019, Merck Biopharma Korea launched Pergoveris Pen, a premixed combination of human FSH (hFSH) and human LH (hLH) for fertility treatment.

Key Takeaways

  • High prevalence of infertility is expected to propel growth of the recombinant human follitropin market over the forecast period
  • Major players operating in the recombinant human follitropin market are focused on R&D to expand their product portfolio. For instance, in June 2021, Ferring presented new data that demonstrated a comparable ongoing pregnancy rate of 31.3% with the individualized dosing regimen of Rekovelle, compared to 25.7% with follitropin alfa amongst all ages in an Asian study population for Individualized fertility treatment, at the 37th Annual Meeting of the European Society of Human Reproduction and Embryology.
  • Major players operating in the recombinant human follitropin market include, Changchun High & New, Merck Serono, Merck, Gen Sci, LIVZON, IBSA, Reproductive Health, and Ferring

The Recombinant Human Follitropin Sales Market report highlights product development and growth strategies such as mergers and acquisitions adopted by market players along with SWOT Analysis, PEST, and Porter’s Five Forces analyses of the Recombinant Human Follitropin Sales Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Changchun High & New
  • Merck Serono
  • Merck(USA)
  • Gen Sci
  • LIVZON
  • IBSA
  • Reproductive Health
  • Ferring

By Product Type, the market is primarily segmented into:

  • RHF-α
  • RHF-β
  • Urofollitropin

By Applications, the market is segmented into:

  • Freeze-Dried Powder Injection
  • Injection

The report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

The objective of the Recombinant Human Follitropin Sales Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Recombinant Human Follitropin Sales Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Recombinant Human Follitropin Sales Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of-the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact the growth of the Recombinant Human Follitropin Sales Market

The Recombinant Human Follitropin Sales Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Recombinant Human Follitropin Sales Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type, and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

1 Report Overview

 

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant Human Follitropin Sales Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Recombinant Human Follitropin Sales Market Share by Application: 2020 VS 2026
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Recombinant Human Follitropin Sales Market
1.6.1 How the Covid-19 is Affecting the Recombinant Human Follitropin Sales Market
1.6.1.1 Recombinant Human Follitropin Sales Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Recombinant Human Follitropin Sales Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

 

2 Global Growth Trends by Regions

 

2.1 Recombinant Human Follitropin Sales Market Perspective (2015-2026)
2.2 Recombinant Human Follitropin Sales Market Growth Trends by Regions
2.2.1 Recombinant Human Follitropin Sales Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Recombinant Human Follitropin Sales Market Historic Market Share by Regions (2015-2020)
2.2.3 Recombinant Human Follitropin Sales Market Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Recombinant Human Follitropin Sales Market Growth Strategy
2.3.6 Primary Interviews with Key Recombinant Human Follitropin Sales Market Players (Opinion Leaders)

 

3 Competition Landscape by Key Players

 

3.1 Global Top Recombinant Human Follitropin Sales Market Players by Market Size
3.1.1 Global Top Recombinant Human Follitropin Sales Market Players by Revenue (2015-2020)
3.1.2 Global Recombinant Human Follitropin Sales Market Revenue Market Share by Players (2015-2020)
3.1.3 Global Recombinant Human Follitropin Sales Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant Human Follitropin Sales Market Concentration Ratio
3.2.1 Global Recombinant Human Follitropin Sales Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Recombinant Human Follitropin Sales Market Revenue in 2019
3.3 Recombinant Human Follitropin Sales Market Key Players Head office and Area Served
3.4 Key Players Recombinant Human Follitropin Sales Market Product Solution and Service
3.5 Date of entering into Recombinant Human Follitropin Sales Market
3.6 Mergers & Acquisitions, Expansion Plans

 

4 Breakdown Data by Type (2015-2026)

 

4.1 Global Recombinant Human Follitropin Sales Market Historic Market Size by Type (2015-2020)
4.2 Global Recombinant Human Follitropin Sales Market Forecasted Market Size by Type (2021-2026)

 

5 Recombinant Human Follitropin Sales Market Breakdown Data by Application (2015-2026)

 

5.1 Global Recombinant Human Follitropin Sales Market Size by Application (2015-2020)
5.2 Global Recombinant Human Follitropin Sales Market Forecasted Market Size by Application (2021-2026)

 

6 North America

 

6.1 North America Recombinant Human Follitropin Sales Market Size (2015-2020)
6.2 Recombinant Human Follitropin Sales Market Key Players in North America (2019-2020)
6.3 North America Recombinant Human Follitropin Sales Market Size by Type (2015-2020)
6.4 North America Recombinant Human Follitropin Sales Market Size by Application (2015-2020)

 

7 Europe

 

7.1 Europe Recombinant Human Follitropin Sales Market Size (2015-2020)
7.2 Recombinant Human Follitropin Sales Market Key Players in Europe (2019-2020)
7.3 Europe Recombinant Human Follitropin Sales Market Size by Type (2015-2020)
7.4 Europe Recombinant Human Follitropin Sales Market Size by Application (2015-2020)

 

8 China

 

8.1 China Recombinant Human Follitropin Sales Market Size (2015-2020)
8.2 Recombinant Human Follitropin Sales Market Key Players in China (2019-2020)
8.3 China Recombinant Human Follitropin Sales Market Size by Type (2015-2020)
8.4 China Recombinant Human Follitropin Sales Market Size by Application (2015-2020)

 

9 Japan

 

9.1 Japan Recombinant Human Follitropin Sales Market Size (2015-2020)
9.2 Recombinant Human Follitropin Sales Market Key Players in Japan (2019-2020)
9.3 Japan Recombinant Human Follitropin Sales Market Size by Type (2015-2020)
9.4 Japan Recombinant Human Follitropin Sales Market Size by Application (2015-2020)

 

10 Southeast Asia

 

10.1 Southeast Asia Recombinant Human Follitropin Sales Market Size (2015-2020)
10.2 Recombinant Human Follitropin Sales Market Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Recombinant Human Follitropin Sales Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant Human Follitropin Sales Market Size by Application (2015-2020)

 

11 India

 

11.1 India Recombinant Human Follitropin Sales Market Size (2015-2020)
11.2 Recombinant Human Follitropin Sales Market Key Players in India (2019-2020)
11.3 India Recombinant Human Follitropin Sales Market Size by Type (2015-2020)
11.4 India Recombinant Human Follitropin Sales Market Size by Application (2015-2020)

 

12 Central & South America

 

12.1 Central & South America Recombinant Human Follitropin Sales Market Size (2015-2020)
12.2 Recombinant Human Follitropin Sales Market Key Players in Central & South America (2019-2020)
12.3 Central & South America Recombinant Human Follitropin Sales Market Size by Type (2015-2020)
12.4 Central & South America Recombinant Human Follitropin Sales Market Size by Application (2015-2020)

 

13 Key Players Profiles

 

13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Recombinant Human Follitropin Sales Market Introduction
13.4 Recombinant Human Follitropin Sales Market Business (2015-2020)
13.5 Recent Development

 

14 Analyst's Viewpoints/Conclusions

 

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

 

List of Table

 

Table 1. Recombinant Human Follitropin Sales Market Key Market Segments
Table 2. Key Players Covered: Ranking by Recombinant Human Follitropin Sales Market Revenue
Table 3. Ranking of Global Top Recombinant Human Follitropin Sales Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Recombinant Human Follitropin Sales Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Recombinant Human Follitropin Sales Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Recombinant Human Follitropin Sales Market Players to Combat Covid-19 Impact
Table 10. Global Recombinant Human Follitropin Sales Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Recombinant Human Follitropin Sales Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Recombinant Human Follitropin Sales Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Recombinant Human Follitropin Sales Market Share by Regions (2015-2020)
Table 14. Global Recombinant Human Follitropin Sales Market Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Recombinant Human Follitropin Sales Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Recombinant Human Follitropin Sales Market Growth Strategy
Table 20. Main Points Interviewed from Key Recombinant Human Follitropin Sales Market Players
Table 21. Global Recombinant Human Follitropin Sales Market Revenue by Players (2015-2020) (Million US$)
Table 22. Global Recombinant Human Follitropin Sales Market Share by Players (2015-2020)
Table 23. Global Top Recombinant Human Follitropin Sales Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Follitropin Sales Market as of 2019)
Table 24. Global Recombinant Human Follitropin Sales Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Recombinant Human Follitropin Sales Market Product Solution and Service
Table 27. Date of entering into Recombinant Human Follitropin Sales Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Recombinant Human Follitropin Sales Market Size by Type (2015-2020) (Million US$)
Table 30. Global Recombinant Human Follitropin Sales Market Size Share by Type (2015-2020)
Table 31. Global Recombinant Human Follitropin Sales Market Revenue Market Share by Type (2021-2026)
Table 31. Global Recombinant Human Follitropin Sales Market Size Share by Application (2015-2020)
Table 33. Global Recombinant Human Follitropin Sales Market Size by Application (2015-2020) (Million US$)
Table 34. Global Recombinant Human Follitropin Sales Market Size Share by Application (2021-2026)
Table 35. North America Key Players Recombinant Human Follitropin Sales Market Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Recombinant Human Follitropin Sales Market Share (2019-2020)
Table 37. North America Recombinant Human Follitropin Sales Market Size by Type (2015-2020) (Million US$)
Table 38. North America Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
Table 39. North America Recombinant Human Follitropin Sales Market Size by Application (2015-2020) (Million US$)
Table 40. North America Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
Table 41. Europe Key Players Recombinant Human Follitropin Sales Market Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Recombinant Human Follitropin Sales Market Share (2019-2020)
Table 43. Europe Recombinant Human Follitropin Sales Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
Table 45. Europe Recombinant Human Follitropin Sales Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
Table 47. China Key Players Recombinant Human Follitropin Sales Market Revenue (2019-2020) (Million US$)
Table 48. China Key Players Recombinant Human Follitropin Sales Market Share (2019-2020)
Table 49. China Recombinant Human Follitropin Sales Market Size by Type (2015-2020) (Million US$)
Table 50. China Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
Table 51. China Recombinant Human Follitropin Sales Market Size by Application (2015-2020) (Million US$)
Table 52. China Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
Table 53. Japan Key Players Recombinant Human Follitropin Sales Market Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Recombinant Human Follitropin Sales Market Share (2019-2020)
Table 55. Japan Recombinant Human Follitropin Sales Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
Table 57. Japan Recombinant Human Follitropin Sales Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Recombinant Human Follitropin Sales Market Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Recombinant Human Follitropin Sales Market Share (2019-2020)
Table 61. Southeast Asia Recombinant Human Follitropin Sales Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
Table 63. Southeast Asia Recombinant Human Follitropin Sales Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
Table 65. India Key Players Recombinant Human Follitropin Sales Market Revenue (2019-2020) (Million US$)
Table 66. India Key Players Recombinant Human Follitropin Sales Market Share (2019-2020)
Table 67. India Recombinant Human Follitropin Sales Market Size by Type (2015-2020) (Million US$)
Table 68. India Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
Table 69. India Recombinant Human Follitropin Sales Market Size by Application (2015-2020) (Million US$)
Table 70. India Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Recombinant Human Follitropin Sales Market Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Recombinant Human Follitropin Sales Market Share (2019-2020)
Table 73. Central & South America Recombinant Human Follitropin Sales Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Recombinant Human Follitropin Sales Market Share by Type (2015-2020)
Table 75. Central & South America Recombinant Human Follitropin Sales Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Recombinant Human Follitropin Sales Market Share by Application (2015-2020)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Recombinant Human Follitropin Sales Market Business (2015-2020) (Million US$)
Table 81. Recent Development

 

List of Figures

 

Figure 1. Global Recombinant Human Follitropin Sales Market Share by Type: 2020 VS 2026
Figure 2. Global Recombinant Human Follitropin Sales Market Share by Application: 2020 VS 2026
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Recombinant Human Follitropin Sales Market Report Years Considered
Figure 8. Global Recombinant Human Follitropin Sales Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Recombinant Human Follitropin Sales Market Share by Regions: 2020 VS 2026
Figure 10. Global Recombinant Human Follitropin Sales Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Recombinant Human Follitropin Sales Market Share by Players in 2019
Figure 13. Global Top Recombinant Human Follitropin Sales Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Follitropin Sales Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Recombinant Human Follitropin Sales Market Revenue in 2019
Figure 15. North America Recombinant Human Follitropin Sales Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Recombinant Human Follitropin Sales Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Recombinant Human Follitropin Sales Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Recombinant Human Follitropin Sales Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Recombinant Human Follitropin Sales Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Recombinant Human Follitropin Sales Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Recombinant Human Follitropin Sales Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.